Dr Sanjay Bhagani invites you to join the 18th European AIDS Conference (EACS 2021). The conference will be organised in a hybrid format from October 27-30, 2021. The onsite Conference in London will take place, following a comprehensive COVID-19 health and safety concept, complemented by an engaging and interactive online platform that mirrors the scientific programme and industry sponsored sessions.
Explore the programme: https://eacs-conference2021.com/programme/scientific-programme/
Trending Topic
Learn about the integration of the latest data in antiretroviral management of HIV, challenges clinicians may face when adopting new strategies and updates from the Conference of Retroviruses and Opportunistic Infections (CROI) 2024 are reported here by Dr Eric Daar, Division of HIV Medicine, Harbor-UCLA Medical Center, Atlanta, GA, USA.
Antiretroviral therapy (ART) effectively manages HIV by suppressing viral replication. It's crucial for healthcare professionals (HCPs) to keep abreast of ART updates for optimal patient care. Dr. Eric Daar, Harbor-UCLA Medical Center, reports on CROI 2024, underscoring the efficacy of long-acting injectable (LAI) therapies in trials like CARES, MOCHA, and LATITUDE. The findings support LAI therapy's potential for global HIV treatment programs, including in resource-limited settings like sub-Saharan Africa.
DANFLU-1 was an open-label, active-controlled, individually randomized trial conducted in Denmark during the 2021/2022 northern hemisphere influenza season. Dr Niklas Dyrby Johansen (University of Copenhagen Copenhagen, Denmark) discusses the post-hoc analysis from DANFLU-1 which investigated the effects of high-dose quadrivalent influenza ...
Respiratory syncytial virus (RSV) present a significant disease burden in children and older adults. Currently, there are no approved vaccines against RSV. In this touchINFECTIOUS DISEASES interview, we met with Prof. Michael Ison (Northwestern University Feinberg School of Medicine, Chicago, ...
Respiratory syncytial virus (RSV) presents a significant disease burden in older adults, with no approved vaccines to protect against RSV. In this touchINFECTIOUS DISEASES interview, we met with Prof. Michael Ison (Northwestern University Feinberg School of Medicine, Chicago, IL, USA) ...
In this touchINFECTIOUS DISEASES interview, we met with Prof. Michael Ison (Northwestern University Feinberg School of Medicine, Chicago, IL, USA) to discuss his highlights from IDWeek 2022. He highlights vaccine development applied outside of COVID-19, and transformational RSV vaccines, antivirals, antifungals ...
Following the recent results from the pivotal Phase III MELODY and Phase IIb trials of nirsevimab in the treatment of respiratory syncytial virus, we were delighted to speak with Dr. Joseph Domachowske (Upstate University Hospital, Syracuse, NY, USA) to discuss ...
Following the recent phase III and phase IIb data for nirsevimab in the treatment of respiratory syncytial virus (RSV), we were delighted to speak with Dr. Joseph Domachowske (Upstate University Hospital, Syracuse, NY, USA) to discuss the unmet needs in ...
World Hepatitis Day takes places every year on 28 July bringing the world together under a single theme to raise awareness of the global burden of viral hepatitis. touchINFECTIOUS DISEASES had the pleasure of speaking with Secretary General of EASL, Prof. ...
Since 13 May 2022, rising cases of monkeypox have been reported to the World Health Organization (WHO) across the United Kingdom and Europe, and even some cases in the US and Canada. Based on currently available information, cases have mainly but not ...
Anakinra is an anti-inflammatory therapy that targets the cytokines IL-1alpha/beta, which play a role in COVID-19-induced hyperinflammation. Prof. Evangelos Giamarellos-Bourboulis (Attikon University Hospital, Chaidari, Greece; Chair, European Sepsis Alliance) discusses the results from the SAVE-MORE phase 3 trial ...
Globally, there have been 166 cases, 17 liver transplants, and one death linked to the recent outbreak of acute hepatitis of unknown origin in children, according to the World Health Organization1 and the European Centre for Disease Prevention and Control2 (data published ...
touchINFECTIOUSDISEASES met with Dr Joshua Parsons Cohen (Independent Healthcare Analyst, Healthcare Analytics, Boston, MA, USA) to discuss the persistence on guideline-recommended HIV treatment, and which treatment regimens were associated with the highest persistence. The abstract entitled: ‘Persistence on guideline-recommended HIV ...
Keep track of your clinical interests and newsletter subscriptions.
Or use a .
Already registered? Login below.
